TCMD Stock Summary and Trading Ideas (Tactile Systems Technology | NASDAQ:TCMD)

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Tactile Systems Technology trades on the NASDAQ stock market under the symbol TCMD.

As of March 20, 2026, TCMD stock price declined to $26.10 with 415,031 million shares trading.

TCMD has a beta of 0.84, meaning it tends to be less sensitive to market movements. TCMD has a correlation of 0.03 to the broad based SPY ETF.

TCMD has a market cap of $585.66 million. This is considered a Small Cap stock.

Last quarter Tactile Systems Technology reported $104 million in Revenue and $.46 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.02.

In the last 3 years, TCMD traded as high as $37.77 and as low as $8.61.

The top ETF exchange traded funds that TCMD belongs to (by Net Assets): VTI, IWM, AVUV, VXF, IWN.

TCMD has outperformed the market in the last year with a return of +90.7%, while the SPY ETF gained +16.6%. However, in the most recent history, TCMD shares have underperformed the stock market with its stock returning -9.8% in the last 3 month period and -9.4% for the last 2 week period, while SPY has returned -4.4% and -3.3%, respectively.

TCMD support price is $26.31 and resistance is $27.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TCMD shares will trade within this expected range on the day.